MIMEDX GROUP, INC. — Director's Dealing 2024

Jul 3, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2024-06-24

Reporting Person: Maersk-Moller Kimberly (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	62383	Direct
Common Stock	18366	Direct
Common Stock	28564	Direct
Common Stock	32488	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$8.63	2031-03-01	Common Stock (39308)		Direct

Footnotes

F1: This filing is made on behalf of a new executive officer to report their existing holdings of MiMedx Securities.

F2: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years from the original grant date of March 2, 2022, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

F3: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years from the original grant date of March 13, 2023, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

F4: Reflects grant of restricted stock units which vests fully on the third anniversary of the grant from the original grant date of March 1, 2024, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

F5: The options granted to the reporting person shall vest 25% on each anniversary of the grant date of March 1, 2024, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.